Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (75)

2024

  1. Hospital pharmacy towards 2030

    Farmacia Hospitalaria, Vol. 48, pp. S52-S58

  2. Observational Study to Compare Biological Drug Concentration Quantification Techniques and Immunogenicity in Patients with Immune-Mediated Diseases

    Biomedicines, Vol. 12, Núm. 4

  3. Patient-reported outcome measures in severe asthma: an expert consensus

    Journal of Asthma, Vol. 61, Núm. 6, pp. 619-631

2023

  1. Agreement between pharmacists and physicians on the assessment of appropriateness of antimicrobial prescribing

    Enfermedades Infecciosas y Microbiologia Clinica

  2. Artículo traducido] Prevalencia de reacciones adversas a medicamentos asociadas a visitas al servicio de urgencias y factores de riesgo de hospitalización

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 1, pp. T20-T25

  3. Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593

  4. Lipid profile changes associated with antiretroviral therapies in a real-world cohort

    Farmacia Hospitalaria, Vol. 47, Núm. 5, pp. 210-217

  5. Medication reconciliation for patients after their discharge from intensive care unit to the hospital ward

    Farmacia Hospitalaria, Vol. 47, Núm. 3, pp. 121-126

  6. Medication reconciliation for patients after their discharge from intensive care unit to the hospital ward

    Farmacia Hospitalaria, Vol. 47, Núm. 3, pp. T121-T126

  7. Outpatient parenteral antimicrobial therapy with continuous infusion of meropenem: A retrospective analysis of three years of clinical experience

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 6, pp. 321-328

  8. Renal profile of patients treated with elvitegravir/ cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort

    European Journal of Hospital Pharmacy, Vol. 30, Núm. 4, pp. 221-226

  9. Telemedicine and severe asthma in our environment: Views on the experience of professionals and suggestions to make it a reality

    Open Respiratory Archives, Vol. 5, Núm. 3

  10. Treatment of high-risk bleeding with susoctocog alfa in a patient with acquired haemophilia A and a nosocomial severe acute respiratory syndrome coronavirus 2 infection

    European Journal of Hospital Pharmacy, Vol. 30, Núm. 3, pp. 177-179

2022

  1. Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago

    Dermatology and Therapy, Vol. 12, Núm. 3, pp. 761-770

  2. Cuadro de mando de Telefarmacia: Indicadores de actividad y calidad de la atención farmacéutica de un servicio de farmacia de hospital

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 7, pp. 92-105

  3. Delayed Pressure Urticaria: Clinical and Diagnostic Features and Response to Omalizumab

    International Archives of Allergy and Immunology, Vol. 183, Núm. 10, pp. 1089-1094

  4. Discontinuation due to neuropsychiatric adverse events with efavirenz-and dolutegravir-based antiretroviral therapy: a comparative real-life study

    European Journal of Hospital Pharmacy, Vol. 29, Núm. 4, pp. 207-211

  5. Evaluation of a Telemedicine pharmaceutical care program for coordination patient's transfer between hospital and primary care, using Telepharmacy

    Farmacia Hospitalaria, Vol. 46, pp. 15-23

  6. Intoxicación por dióxido de cloro

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 5, pp. 308-310

  7. Process of medical nutrition therapy

    Nutricion Hospitalaria, Vol. 39, Núm. 5, pp. 1166-1189